Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

A pilot study of chronic recombinant interferon-alfa 2a for diabetic proliferative retinopathy: metabolic effects and opthalmologic effects.

Skowsky WR, Siddiqui T, Hodgetts D, Lambrou FH Jr, Stewart MW, Foster MT Jr.

J Diabetes Complications. 1996 Mar-Apr;10(2):94-9.

PMID:
8777337
2.

Interferon alpha-2a for proliferative diabetic retinopathy after complete laser panretinal photocoagulation treatment.

Leibovitch I, Loewenstein A, Alster Y, Rosenblatt I, Lazar M, Yassur Y, Rubinstein A.

Ophthalmic Surg Lasers Imaging. 2004 Jan-Feb;35(1):16-22.

PMID:
14750758
3.

Diabetic retinopathy assessed by fundus photography in Pima Indians with impaired glucose tolerance and NIDDM.

Nagi DK, Pettitt DJ, Bennett PH, Klein R, Knowler WC.

Diabet Med. 1997 Jun;14(6):449-56.

PMID:
9212309
5.

[Diabetes self-management and its association with diabetic retinopathy in patients with type 2 diabetes].

Li N, Yang XF, Deng Y, Gu H, Ren XT, Xu J, Ma K, Liu NP.

Zhonghua Yan Ke Za Zhi. 2013 Jun;49(6):500-6. Chinese.

PMID:
24119962
6.
7.

Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.

Simó R, Lecube A, Segura RM, García Arumí J, Hernández C.

Am J Ophthalmol. 2002 Sep;134(3):376-82.

PMID:
12208249
8.

Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius.

Dowse GK, Humphrey AR, Collins VR, Plehwe W, Gareeboo H, Fareed D, Hemraj F, Taylor HR, Tuomilehto J, Alberti KG, Zimmet PZ.

Am J Epidemiol. 1998 Mar 1;147(5):448-57.

PMID:
9525531
9.

Retinopathy as a predictor of other diabetic complications.

El-Asrar AM, Al-Rubeaan KA, Al-Amro SA, Moharram OA, Kangave D.

Int Ophthalmol. 2001;24(1):1-11.

PMID:
11998880
10.

Retrospective analysis of rosiglitazone and macular oedema in patients with type 2 diabetes mellitus.

Tatti P, Arrigoni F, Longobardi A, Costanza F, Di Blasi P, Merante D.

Clin Drug Investig. 2008;28(5):327-32.

PMID:
18407718
11.
12.

Optos-guided pattern scan laser (Pascal)-targeted retinal photocoagulation in proliferative diabetic retinopathy.

Muqit MM, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, Stanga PE.

Acta Ophthalmol. 2013 May;91(3):251-8. doi: 10.1111/j.1755-3768.2011.02307.x. Epub 2011 Dec 16.

13.

Chronic diabetic complications in patients with MODY3 diabetes.

Isomaa B, Henricsson M, Lehto M, Forsblom C, Karanko S, Sarelin L, Häggblom M, Groop L.

Diabetologia. 1998 Apr;41(4):467-73.

PMID:
9562352
15.

Treatment of nonproliferative diabetic retinopathy with Defibrotide in noninsulin-dependent diabetes mellitus: a pilot study.

Vingolo EM, De Mattia G, Giusti C, Forte R, Laurenti O, Pannarale MR.

Acta Ophthalmol Scand. 1999 Jun;77(3):315-20.

17.

Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota.

Dwyer MS, Melton LJ 3rd, Ballard DJ, Palumbo PJ, Trautmann JC, Chu CP.

Diabetes Care. 1985 Jul-Aug;8(4):316-22.

PMID:
4042796
18.

Relations between diabetic retinopathy and cardiovascular neuropathy--a cross-sectional study in IDDM and NIDDM patients.

Zander E, Heinke P, Herfurth S, Reindel J, Ostermann FE, Kerner W.

Exp Clin Endocrinol Diabetes. 1997;105(6):319-26.

PMID:
9439926
19.

Diabetes complications in NIDDM kindreds linked to the MODY3 locus on chromosome 12q.

Velho G, Vaxillaire M, Boccio V, Charpentier G, Froguel P.

Diabetes Care. 1996 Sep;19(9):915-9.

PMID:
8875082
20.

Pancreas transplant alone has beneficial effects on retinopathy in type 1 diabetic patients.

Giannarelli R, Coppelli A, Sartini MS, Del Chiaro M, Vistoli F, Rizzo G, Barsotti M, Del Prato S, Mosca F, Boggi U, Marchetti P.

Diabetologia. 2006 Dec;49(12):2977-82. Epub 2006 Oct 5.

PMID:
17021920

Supplemental Content

Support Center